Related Experiment Video
Updated: Oct 29, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
Transmyocardial laser revascularization in the treatment of end-stage coronary artery disease
T Krabatsch1, L Tambeur, E Lieback
1Department of Cardio-thoracic and Vascular Surgery, Deutsches Herzzentrum Berlin, Augustenburger Platz 1, D-13353 Berlin, Germany.
Insights
Transmyocardial laser revascularization (TMR) provided angina relief and improved endurance in severe angina patients. While not improving myocardial function, TMR showed reduced mortality and justified its use in select cases.
Area of Science:
- Cardiology
- Minimally Invasive Surgery
Background:
- Severe angina pectoris often presents in patients unresponsive to medical therapy.
- Conventional treatments like bypass surgery or PTCA may not be suitable for all severe angina patients.
Purpose of the Study:
- To evaluate the efficacy and safety of Transmyocardial laser revascularization (TMR) in patients with severe angina pectoris.
- To assess TMR's impact on angina symptoms, physical endurance, myocardial perfusion, and left ventricular contractility.
Main Methods:
- Transmyocardial laser revascularization (TMR) was performed on 171 patients between July 1994 and December 1997.
- Patients included those for whom conventional bypass surgery or PTCA were not viable options.
Main Results:
- A significant decrease in angina symptoms and improved physical endurance were observed in most patients post-TMR.
- No statistically significant increase in myocardial perfusion or left ventricular contractility was detected.
- Perioperative mortality decreased from 8% to 2.5% over the study period, with an overall mortality of 7%.
Conclusions:
- TMR appears to justify its use for symptom relief and improved quality of life in carefully selected patients with severe angina.
- Further research is needed to conclusively assess the long-term effects and definitive role of TMR due to its experimental nature.
Abstract:
Transmyocardial laser revascularization has been used in 171 patients suffering from severe angina pectoris unresponsive to medical therapy at Deutsches Herzzentrum Berlin within the period from 7/1994 to 12/1997. In all patients conventional bypass surgery or PTCA, did not seem to offer the possibility of success. Postoperatively, the majority of the patients experienced a significant decrease in angina and better physical endurance. A statistically significant increase in myocardial perfusion or left ventricular contractility has not been detected. Perioperative mortality after TMR decreased from 8% among the first 40 patients to 2.5% among the 40 patients operated on most recently, with an overall mortality of 7%. The relief of angina symptoms and the improved quality of life after TMR seems to justify the use of the method in patients who presented with urgent indications for CABG surgery, although their coronary vessel status did not seem to promise success for this procedure. However, considering its experimental foundation and long-term effects, it seems that a conclusive assessment of TMR is not yet possible.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Cardiomyopathy IV: Restrictive Cardiomyopathy
Acute Coronary Syndrome I: Introduction
Atherosclerosis III: Management
